STAT Plus: Alector, with big ideas about treating dementia, presents a little bit of data
Alector, a South San Francisco-based biotech, raised $176 million in an initial public offering in…
Author: STAT
Scientists find new way to kill disease-carrying mosquitoes
NEW YORK — Scientists say they nearly eliminated disease-carrying mosquitoes on two islands in China…
An experimental AI system can predict when pancreatic cysts will become cancerous
Pancreatic cancer often kills people because they are diagnosed too late, after their tumors have…
WHO declares Ebola outbreak an international health emergency
The World Health Organization declared the Ebola outbreak in the Democratic Republic of the Congo…
STAT Plus: Pharma deploys its top guns to Capitol Hill as senators mull drug pricing package
WASHINGTON — The pharmaceutical industry deployed its top guns to Capitol Hill on Wednesday as…
STAT Plus: An Indian drug maker sent records to its scrapyard before the FDA visited
As concerns persist over the quality of medicines made in Asia, a recent episode involving…
STAT Plus: Frequency signs $80 million deal with Astellas Pharma
Frequency Therapeutics, the Woburn, Mass., biotech that wants to restore hearing lost as a result…
STAT Plus: Tracking Washington’s moves on drug pricing
WASHINGTON — From bombastic White House speeches (and tweets) to a flurry of legislation introduced…
New clues on why women’s Alzheimer’s risk differs from men’s
LOS ANGELES — New research gives some biological clues to why women may be more…
How the drug industry keeps winning in Washington
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….
Opinion: State drug importation programs will work with the FDA, not outside of it
The safety of the supply chain for pharmaceuticals in the United States must be built…
STAT Plus: Pharmalittle: Pharma keeps winning in Washington; J&J faces test as Oklahoma opioid trial wraps up
Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy…
Kamala Harris becomes the latest Democratic candidate to zero in on drug prices
WASHINGTON — Sen. Kamala Harris (D-Calif.) on Tuesday became the second leading Democratic primary candidate…
STAT Plus: GSK took a leap of faith on PARP inhibitors in cancer. It may pay off
When GlaxoSmithKline (GSK) purchased Tesaro for $5 billion last December, one of the company’s big…
Opinion: Fixing health care’s replication crisis is important for researchers and patients
We are awash in articles reporting new study results. Whether it’s a potential cure for…
STAT Plus: The FDA disagrees with its own expert panels how often?
As the Food and Drug Administration grapples with rising pressure to approve new medicines more…
Scientists close in on blood test for Alzheimer’s
LOS ANGELES — Scientists are closing in on a long-sought goal — a blood test…
STAT Plus: Weeks after Kymera signed $70m deal with Vertex, the biotech’s CEO is out
Laurent Audoly, CEO and president of Kymera Therapeutics, left the Cambridge, Mass., biotech late last…
Biden puts forth an elaborate — and aggressive — plan to lower drug prices
WASHINGTON — Joe Biden on Monday unveiled a sweeping health policy platform that includes some…
STAT Plus: Pharmalittle: Glaxo is set to hire a new chairman; Gilead tries to bulk up with new deal
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Biden Cancer Initiative to suspend operations as 2020 campaign heats up
The Biden Cancer Initiative, the nonprofit former Vice President Joe Biden started two years ago…
In a small study, a cancer vaccine assist beats immunotherapy drugs alone
The largest study to date of a “cancer vaccine” plus one of the immunotherapy drugs…
STAT Plus: With $5 billion Galapagos deal, CEO Daniel O’Day starts putting his stamp on Gilead
Daniel O’Day was made CEO of Gilead Sciences four-and-a-half months ago, charged with reigniting investor…
A healthy lifestyle may offset genetic risk for Alzheimer’s
LOS ANGELES — A healthy lifestyle can cut your risk of developing Alzheimer’s or other…
STAT Plus: Lawmakers urge Trump administration to alter trade deal or Americans will pay more for drugs
More than 100 Democratic members of Congress urged the Trump administration to remove pending language…
STAT Plus: Illumina earnings points to worrying signs for consumer genetics industry
If you look closely at Thursday’s bad news from Illumina (ILMN), the multibillion-dollar standard-bearer of…
STAT Plus: Mass. Gov. Charlie Baker’s plan to curb drug prices strains his relationship with biotechs
Massachusetts’ booming biotech industry has long enjoyed a tight — some would say coddling —…
STAT Plus: Pharmalittle: Trump abandons rebate rule; biotechs fume at Mass. governor’s plan to lower drug prices
Top of the morning, to you, and a fine one it is. A delicious breeze…
STAT Plus: Reckitt will pay $1.4 billion to settle federal probes into marketing of opioid-addiction treatment
Reckitt Benckiser agreed to pay up to $1.4 billion to resolve long-running investigations by the…
Trump abandons drug pricing proposal that would have ended certain drug rebates
WASHINGTON — The Trump administration on Wednesday abandoned one of its signature drug-pricing efforts: a…
After limits on residency work hours, did doctors perform worse? New study says no
Physician training has long been notorious for marathon shifts, sleepless nights on call, and holidays…
Opinion: State drug importation laws undermine the process that keeps our supply chain safe
Three states — Vermont, Florida, and Colorado — recently passed laws that legalize the importation…
Opinion: We love primary care. Why are our trainees so discouraged by it?
We have been primary care physicians for a combined total of 98 years. Every day…
STAT Plus: Pharma continues to get poor grades when it comes to sharing clinical trial data
Amid ongoing concerns that clinical trial data is too often kept under wraps, an analysis…
Trump directs government to revamp nation’s care for kidney disease
WASHINGTON — President Donald Trump signed an executive order directing the government to revamp the…
STAT Plus: Pharmalittle: White House edges near drug deal with Capitol Hill; U.K. offers plan for antibiotic development
Rise and shine, everyone, the middle of the week is already here. But time waits…
STAT Plus: Top Trump advisers hint at support for progressive proposal to cap drug price hikes
WASHINGTON — A trio of key White House advisers on Tuesday hinted for the first…
Opinion: Pregnancy-related deaths reflect how implicit bias harms women. We need to fix that
I have had babies, delivered other women’s babies, and worked in a bustling, diverse maternity…
Opinion: Pharmaceutical mergers and megamergers stifle innovation
It isn’t lost on the public that the pharmaceutical industry is putting profits over people….
STAT Plus: 5 burning questions about deploying voice recognition technology in health care
Voice assistant technologies like Amazon Alexa and Google Assistant are increasingly popular — today, nearly…
With a surge in cases of mysterious polio-like condition, CDC appeals to doctors to help crack case
The Centers for Disease Control and Prevention on Tuesday appealed to doctors to rapidly report…
STAT Plus: Do doctors prescribe more Lyrica and similar painkillers because they receive pharma money?
Amid ongoing concern that painkillers other than opioids are being misused, a new analysis suggests…
So much for Trump’s rule about drug prices in TV ads
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….
STAT Plus: Pharmalittle: Judge blocks Trump plan to run drug prices in TV ads; former Insys execs cooperate with the feds
Hello, everyone, and how are you today? We are doing just fine, thank you, since…
STAT Plus: Johnson & Johnson partners with Celsius Therapeutics in large-scale test of single-cell sequencing
Celsius Therapeutics, a startup built around sequencing genetic material in thousands of an individual’s cells,…
Opinion: Trustworthy data from consumer health devices can help solve stubborn health care challenges
Americans collectively spend more on pregnancy and childbirth than any other nation yet have the…
STAT Plus: The Parker Institute looks to grow, leveraging outside donors and equity stakes
LOS ANGELES — Internet billionaire Sean Parker has spent hundreds of millions of dollars of…
STAT Plus: Pharmalittle: Trump plans drug-pricing order; U.S. seeks extradition of Chinese researcher over trade secrets
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
STAT Plus: Takeda, already a giant in Mass. biopharma, plans a bigger footprint
Six months ago, Tokyo-based Takeda Pharmaceutical closed a blockbuster $62 billion deal to buy Shire,…
Opinion: After 50 years of ‘health crisis,’ chuck the Chicken Little rhetoric
Although Americans love anniversaries, we have overlooked the political importance of July 10, 1969. Speaking…